| Filed On | Filing |
|---|---|
| 09 Nov 2026 |
8-K/A: Financial Statements and Exhibits
As previously announced, on June 28, 2026, Zymeworks Inc. (“Zymeworks” or the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Theravance Biopharma, Inc. (“Theravance”) and Zymeworks Merger Sub 1, a w... |
Loading...